Open AccessErysipeloid rash: A rare adverse event induced by gemcitabine
Author(s) -
Ana Ruiz-Casado,
David Gutiérrez,
Ignacio Juez
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.148711
Subject(s) - medicine , gemcitabine , rash , adverse effect , erysipelas , dermatology , cancer
Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema